241 related articles for article (PubMed ID: 26852276)
1. Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma.
Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
Am J Hematol; 2016 May; 91(5):476-80. PubMed ID: 26852276
[TBL] [Abstract][Full Text] [Related]
2. Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.
Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):126-132. PubMed ID: 26547384
[TBL] [Abstract][Full Text] [Related]
3. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
[TBL] [Abstract][Full Text] [Related]
4. Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?
Vargo JA; Gill BS; Balasubramani GK; Beriwal S
J Clin Oncol; 2015 Nov; 33(32):3710-7. PubMed ID: 26261253
[TBL] [Abstract][Full Text] [Related]
5. Role of radiation therapy in primary mediastinal large B-cell lymphoma in rituximab era: A US population-based analysis.
Giri S; Bhatt VR; Pathak R; Bociek RG; Vose JM; Armitage JO
Am J Hematol; 2015 Nov; 90(11):1052-4. PubMed ID: 26270899
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy in primary mediastinal B-cell lymphoma with positron emission tomography positivity after rituximab chemotherapy.
Filippi AR; Piva C; Giunta F; Bellò M; Chiappella A; Caracciolo D; Zotta M; Douroukas A; Ragona R; Vitolo U; Bisi G; Ricardi U
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):311-6. PubMed ID: 23916170
[TBL] [Abstract][Full Text] [Related]
7. Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?
Laskar S; Bahl G; Muckaden MA; Nair R; Gupta S; Bakshi A; Gujral S; Shet T; Shrivastava SK; Dinshaw KA
Cancer; 2007 Aug; 110(4):816-23. PubMed ID: 17582622
[TBL] [Abstract][Full Text] [Related]
8. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
Avilés A; García EL; Fernández R; Gonzalez JL; Neri N; Díaz-Maqueo JC
Ann Hematol; 2002 Jul; 81(7):368-73. PubMed ID: 12185505
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma.
Xu LM; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Liu QF; Chen B; Qi SN; Ren H; Dai JR
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1289-95. PubMed ID: 23245279
[TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base.
Amini A; Jones BL; Yeh N; Rusthoven CG; Armstrong H; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1052-63. PubMed ID: 26581142
[TBL] [Abstract][Full Text] [Related]
11. What is the optimal management of early-stage low-grade follicular lymphoma in the modern era?
Vargo JA; Gill BS; Balasubramani GK; Beriwal S
Cancer; 2015 Sep; 121(18):3325-34. PubMed ID: 26042364
[TBL] [Abstract][Full Text] [Related]
12. Management Trends and Outcomes for Stage I to II Mantle Cell Lymphoma Using the National Cancer Data Base: Ascertaining the Ideal Treatment Paradigm.
Gill BS; Vargo JA; Pai SS; Balasubramani GK; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):668-76. PubMed ID: 26461009
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.
Barzenje DA; Cvancarova Småstuen M; Liestøl K; Fosså A; Delabie J; Kolstad A; Holte H
PLoS One; 2015; 10(7):e0131158. PubMed ID: 26147646
[TBL] [Abstract][Full Text] [Related]
14. Primary mediastinal B-cell lymphoma with sclerosis: report of 11 cases treated with intensified-CHOP plus radiotherapy.
Siracusano L; Balzarotti M; Magagnoli M; Castagna L; Rahal D; Santoro A
Am J Hematol; 2005 Apr; 78(4):312-3. PubMed ID: 15795908
[TBL] [Abstract][Full Text] [Related]
15. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
16. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.
Corso CD; Rutter CE; Park HS; Lester-Coll NH; Kim AW; Wilson LD; Husain ZA; Lilenbaum RC; Yu JB; Decker RH
J Clin Oncol; 2015 Dec; 33(36):4240-6. PubMed ID: 26481366
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E
Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
[TBL] [Abstract][Full Text] [Related]
18. Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis.
Haque W; Dabaja B; Tann A; Khan M; Szeja S; Butler EB; Teh BS
Radiother Oncol; 2016 Jul; 120(1):150-5. PubMed ID: 27373911
[TBL] [Abstract][Full Text] [Related]
19. The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States.
Vargo JA; Patel A; Glaser SM; Balasubramani GK; Farah RJ; Marks SM; Beriwal S
Cancer; 2017 Aug; 123(16):3176-3185. PubMed ID: 28380259
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Treatment in Slovene Follicular Lymphoma Patients.
Južnič Šetina T; Borštnar S; Jezeršek Novaković B
Clin Lymphoma Myeloma Leuk; 2015 Oct; 15(10):586-91. PubMed ID: 26423702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
